Synthetic mRNA capping

Scholarly Works

• Kumar, D.; Singh, A.; Kaviraj, S.; Singh, S. Unveiling Fundamentals and Research Opportunities of mRNA Technology. Biotechnology in India - Reworking A Strategy; Springer Nature Singapore, 2024; pp 113–146. doi:10.1007/978-981-97-0896-3_5
• Karimi-Sani, I.; Molavi, Z.; Naderi, S.; Mirmajidi, S.-H.; Zare, I.; Naeimzadeh, Y.; Mansouri, A.; Tajbakhsh, A.; Savardashtaki, A.; Sahebkar, A. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials. Journal of nanobiotechnology 2024, 22, 601. doi:10.1186/s12951-024-02882-x
• Rothweiler, U.; Gundesø, S. E.; Mikalsen, E. W.; Svenning, S.; Singh, M.; Combes, F.; Pettersson, F. J.; Mangold, A.; Piotrowski, Y.; Schwab, F.; Lanes, O.; Striberny, B. K. Using nucleolytic toxins as restriction enzymes enables new RNA applications. Nucleic acids research 2024, 52, e90. doi:10.1093/nar/gkae779
• Bartosik, K.; Micura, R. Access to capped RNAs by chemical ligation. RSC chemical biology 2024. doi:10.1039/d4cb00165f
• Hou, X.; Shi, J.; Xiao, Y. mRNA medicine: Recent progresses in chemical modification, design, and engineering. Nano Research 2024, 17, 9015–9030. doi:10.1007/s12274-024-6978-6
• Phan, T.; Fan, D.; Melstrom, L. G. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations. Current oncology (Toronto, Ont.) 2024, 31, 4855–4884. doi:10.3390/curroncol31090361
• Xing, L.; Wang, Z.-K.; Li, D.-M.; Li, J.; Liu, M. RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives. Hepatoma Research 2024. doi:10.20517/2394-5079.2024.25
• Narasipura, E. A.; Fenton, O. S. Advances in non-viral mRNA delivery to the spleen. Biomaterials science 2024, 12, 3027–3044. doi:10.1039/d4bm00038b
• Jolly, K. J.; Zhang, F. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy. Advances in pharmacology (San Diego, Calif.) 2024, 100, 247–288. doi:10.1016/bs.apha.2024.04.004
• Song, J.; Zhang, Y.; Zhou, C.; Zhan, J.; Cheng, X.; Huang, H.; Mao, S.; Zong, Z. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy. International immunopharmacology 2024, 132, 112037. doi:10.1016/j.intimp.2024.112037
• Mahony, T. J.; Briody, T. E.; Ommeh, S. C. Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?. Vaccines 2024, 12, 152. doi:10.3390/vaccines12020152
• Oude Blenke, E.; Schiffelers, R. M.; Mastrobattista, E. Oligonucleotides and mRNA Therapeutics. Pharmaceutical Biotechnology; Springer International Publishing, 2024; pp 291–321. doi:10.1007/978-3-031-30023-3_13
• Sharma, P.; Hoorn, D.; Aitha, A.; Breier, D.; Peer, D. The immunostimulatory nature of mRNA lipid nanoparticles. Advanced drug delivery reviews 2024, 205, 115175. doi:10.1016/j.addr.2023.115175
• Pan, S.; Fan, R.; Han, B.; Tong, A.; Guo, G. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy. Trends in immunology 2023, 45, 20–31. doi:10.1016/j.it.2023.11.003
• Inagaki, M. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine. Journal of developmental biology 2023, 12, 1. doi:10.3390/jdb12010001
• Menneteau, T.; Butré, C. I.; Mouvet, D.; Delobel, A. Multi-Attribute Monitoring of Therapeutic mRNA by Liquid Chromatography–Mass Spectrometry. LCGC Europe 2023, 18–24. doi:10.56530/lcgc.eu.fd3584v4
• Neill, B.; Romero, A. R.; Fenton, O. S. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy. ACS applied bio materials 2023, 7, 4894–4913. doi:10.1021/acsabm.3c00721
• Chan, S. H.; Tirole, L.; Kneller, D.; Kelley, T. M.; Dai, N.; Robb, G. B. Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein. Cold Spring Harbor Laboratory 2023. doi:10.1101/2023.10.28.564488
• Che, S.; Feng, X.; Li, Z.; Su, Z.; Ma, G.; Li, Z.; Yu, A.; Liu, M.; Zhang, S. On-column capping of poly dT media-tethered mRNA accomplishes high capping efficiency, enhanced mRNA recovery, and improved stability against RNase. Biotechnology and bioengineering 2023, 121, 206–218. doi:10.1002/bit.28560
• Noël, M.; Guez, T.; Thillier, Y.; Vasseur, J.-J.; Debart, F. Access to High-Purity 7m G-cap RNA in Substantial Quantities by a Convenient All-Chemical Solid-Phase Method. Chembiochem : a European journal of chemical biology 2023, 24, e202300544. doi:10.1002/cbic.202300544

Explore citations to this article at